[
    [
        {
            "time": "",
            "original_text": "对话智飞生物董事长蒋仁生 复盘3000亿市值的资本棋局",
            "features": {
                "keywords": [
                    "智飞生物",
                    "董事长",
                    "蒋仁生",
                    "资本棋局",
                    "3000亿市值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "对话智飞生物董事长蒋仁生 复盘3000亿市值的资本棋局",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物蒋仁生：布局未来 借力资本市场加大自主研发投入",
            "features": {
                "keywords": [
                    "智飞生物",
                    "蒋仁生",
                    "布局未来",
                    "资本市场",
                    "自主研发",
                    "投入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物蒋仁生：布局未来 借力资本市场加大自主研发投入",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "生物医药行业周报：“三胎”政策发布 辅助生殖为直接受益行业",
            "features": {
                "keywords": [
                    "生物医药",
                    "行业周报",
                    "三胎政策",
                    "辅助生殖",
                    "受益行业"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "辅助生殖"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物医药行业周报：“三胎”政策发布 辅助生殖为直接受益行业",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]